WGS · ISSUER CIK 1818331
GeneDx Holdings Corp.
Between Aug 1, 2026 and Oct 29, 2026, 3 GeneDx Holdings Corp. insiders reported $0.00 of open-market purchases and $1.8M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.8MInsider selling
−$1.8MNet open-market
Sep 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202616:43 | Sep 16, 2026 | WGS | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $97.61 | −10,501 | 115,476 | -8% | −$1.0M | ||
| Sep 18, 202616:43 | Sep 16, 2026 | WGS | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | — | +18,750 | 125,977 | +17% | — | ||
| Sep 18, 202616:39 | Sep 16, 2026 | WGS | CHIEF FINANCIAL OFFICER | S · Sell | $97.61 | −3,728 | 44,945 | -8% | −$364K | ||
| Sep 18, 202616:39 | Sep 16, 2026 | WGS | CHIEF FINANCIAL OFFICER | M · Exercise | — | +7,197 | 48,673 | +17% | — | ||
| Sep 18, 202616:37 | Sep 17, 2026 | WGS | Director | M · Exercise | — | +1,146 | 1,146 | New | — | ||
| Sep 11, 202616:13 | Sep 9, 2026 | WGS | CHIEF EXECUTIVE OFFICER, Director | S · Sell | $84.22 | −3,692 | 107,227 | -3% | −$311K | ||
| Sep 11, 202616:13 | Sep 9, 2026 | WGS | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | — | +6,547 | 110,919 | +6% | — | ||
| Sep 11, 202616:10 | Sep 9, 2026 | WGS | CHIEF FINANCIAL OFFICER | S · Sell | $84.22 | −1,285 | 41,476 | -3% | −$108K | ||
| Sep 11, 202616:10 | Sep 9, 2026 | WGS | CHIEF FINANCIAL OFFICER | M · Exercise | — | +2,462 | 42,761 | +6% | — | ||
| Sep 3, 202616:09 | Sep 1, 2026 | WGS | CHIEF FINANCIAL OFFICER | S · Sell | $83.84 | −372 | 40,299 | -1% | −$31K | ||
| Sep 3, 202616:09 | Sep 1, 2026 | WGS | CHIEF FINANCIAL OFFICER | M · Exercise | — | +717 | 40,671 | +2% | — |